Invention Grant
- Patent Title: Modified factor VIII
- Patent Title (中): 修改因子VIII
-
Application No.: US13431085Application Date: 2012-03-27
-
Publication No.: US08951515B2Publication Date: 2015-02-10
- Inventor: John S. Lollar
- Applicant: John S. Lollar
- Applicant Address: US GA Atlanta
- Assignee: Emory University
- Current Assignee: Emory University
- Current Assignee Address: US GA Atlanta
- Agency: Lathrop & Gage LLP
- Main IPC: A61K38/37
- IPC: A61K38/37 ; C07K14/755 ; C12N15/17 ; C12N15/85
Abstract:
Methods of treating patients with Factor VIII deficiency by administration of modified porcine factor VIII are disclosed. The particular modified porcine factor VIII is one in which most of the B domain has been removed through genetic engineering. This modified factor VIII is particularly useful for treatment of hemophiliacs, especially those undergoing bleeding episodes.
Public/Granted literature
- US20130005656A1 Modified Factor VIII Public/Granted day:2013-01-03
Information query
IPC分类:
